1. Home
  2. ICCM vs OXBR Comparison

ICCM vs OXBR Comparison

Compare ICCM & OXBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

HOLD

Current Price

$2.21

Market Cap

8.3M

Sector

N/A

ML Signal

HOLD

Logo Oxbridge Re Holdings Limited

OXBR

Oxbridge Re Holdings Limited

N/A

Current Price

$1.44

Market Cap

8.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ICCM
OXBR
Founded
2006
2013
Country
Israel
Cayman Islands
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
8.3M
8.1M
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
ICCM
OXBR
Price
$2.21
$1.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$2.50
$5.00
AVG Volume (30 Days)
89.0K
22.2K
Earning Date
05-27-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.78
EPS
N/A
0.02
Revenue
N/A
$2,577,000.00
Revenue This Year
$139.51
$80.09
Revenue Next Year
$75.66
$85.22
P/E Ratio
N/A
$72.00
Revenue Growth
N/A
371.98
52 Week Low
$0.13
$0.66
52 Week High
$9.54
$2.85

Technical Indicators

Market Signals
Indicator
ICCM
OXBR
Relative Strength Index (RSI) 33.57 57.54
Support Level $2.15 $1.21
Resistance Level $3.59 $1.45
Average True Range (ATR) 0.16 0.08
MACD 0.01 0.01
Stochastic Oscillator 10.45 95.80

Price Performance

Historical Comparison
ICCM
OXBR

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

About OXBR Oxbridge Re Holdings Limited

Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer that provides reinsurance solutions through its subsidiary. The company focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. It specializes in underwriting medium-frequency, high-severity risks where insufficient data exists to effectively analyze the risk/return profile of reinsurance contracts. The company generates revenue from three principal sources: premiums assumed from reinsurance on property and casualty business; income from investments, including unrealized gains or losses on other investments; and income from SurancePlus management fees.

Share on Social Networks: